| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.45B | 1.49B | 1.49B | 1.46B | 1.36B |
| Gross Profit | 738.02M | 786.18M | 794.55M | 739.54M | 682.95M |
| EBITDA | 229.91M | 258.63M | 285.38M | 273.45M | 258.87M |
| Net Income | 33.81M | 23.91M | 57.71M | 67.78M | 80.37M |
Balance Sheet | |||||
| Total Assets | 1.18B | 1.21B | 1.29B | 1.32B | 1.32B |
| Cash, Cash Equivalents and Short-Term Investments | 207.70M | 206.02M | 220.64M | 256.13M | 290.29M |
| Total Debt | 203.86M | 233.75M | 274.60M | 257.01M | 234.76M |
| Total Liabilities | 531.74M | 578.18M | 625.90M | 668.02M | 676.22M |
| Stockholders Equity | 649.44M | 635.42M | 660.19M | 655.82M | 644.35M |
Cash Flow | |||||
| Free Cash Flow | 173.06M | 200.76M | 181.08M | 173.62M | 152.22M |
| Operating Cash Flow | 218.93M | 238.86M | 219.10M | 234.23M | 202.31M |
| Investing Cash Flow | -52.77M | -34.91M | -32.75M | -59.60M | -119.00M |
| Financing Cash Flow | -165.83M | -218.46M | -221.55M | -206.30M | -166.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$455.76M | 6.04 | 10.82% | 4.07% | 3.68% | ― | |
71 Outperform | HK$401.20M | 5.00 | 8.56% | 3.63% | -1.49% | 32.28% | |
69 Neutral | HK$303.19M | 7.47 | 5.23% | 6.06% | -2.76% | 41.23% | |
67 Neutral | HK$367.57M | 9.45 | 8.14% | 7.38% | 9.44% | -27.68% | |
65 Neutral | HK$489.70M | 1.04 | 10.76% | 13.51% | -9.65% | 101.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |